News &

Media Contact

Amy Merves
Manager of
Media Relations



Daniel M. Geynisman, MD, Joins Fox Chase Cancer Center’s Department of Medical Oncology

PHILADELPHIA, PA (July 25, 2013)—Daniel M. Geynisman, MD, has joined Fox Chase’s department of medical oncology after completing a hematology/oncology fellowship at the University of Chicago Medical Center, where he served as chief fellow in his final year. While there, he completed an additional fellowship at the MacLean Center for Clinical Medical Ethics. He specializes in treating patients with genitourinary cancers, including prostate, bladder, kidney, testicular, penile, and adrenal cancers.

Dr. Geynisman earned his medical degree from the University of Pittsburgh School of Medicine and completed a residency in internal medicine at the University of Pittsburgh Medical Center, serving an additional year as chief resident. Before enrolling in medical school, he worked as a mental health counselor at Linden Oaks Hospital in Naperville, Ill., having received his undergraduate degree in psychology from Northwestern University.

Dr. Geynisman’s research focuses on health outcomes, such as adherence to oral anticancer drugs; medical ethics; and clinical trials development for genitourinary cancers. He is fluent in Russian as well as English.

Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, call 1-888-FOX CHASE or (1-888-369-2427).

More 2013 News Releases »